May 19, 2020
AllianceRx Walgreens Prime one of only two specialty pharmacies to distribute Vyepti(TM), the first and only intravenous preventive treatment for migraine
Apr 22, 2020
Orsini Pharmaceutical Services Selected To Provide VYEPTI(TM) (eptinezumab-jjmr) - The First And Only Intravenous Preventive Treatment For Migraine
Mar 09, 2020
The Global Epilepsy Market, Pipeline and Competition 2020-2030 - Aquestive Therapeutical's AQST-203 Will Be a Blockbuster Drug
Feb 19, 2020
Global Acute Agitation and Aggression Treatment Market Industry Analysis 2019-2027 with Key Market Forecasts
Jan 27, 2020
Tuberous Sclerosis Alliance Lauds Lundbeck And FDA For Sabril Label Expansion For Patients 2 To 10 Years Old
Sep 16, 2019
Alder (ALDR) Alert: Johnson Fistel Investigates Proposed Sale of Alder BioPharmaceuticals, Inc.; Are Shareholders Getting a Fair Deal?
Sep 12, 2019
Global Neurology Market Research Overview 2019: Competitive Environment, Regulations, Epidemiology, M&As, Pipeline Drugs
May 16, 2019
Visiongain Report Claims there is Huge Potential within the $14bn Antidepressant and Anti-Anxiety Drugs Market
Mar 26, 2019
Enamine Extends Multi-Year Drug Discovery Collaboration with Lundbeck
Mar 18, 2019
The Worldwide Antidepressant Market to 2024 - Emergence of Novel Biologics Bodes Well for Growth
Jan 30, 2019
Epilepsy - Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Nov 02, 2018
Aquestive Therapeutics Announces U.S. Food and Drug Administration (FDA) Approval for SYMPAZAN(TM) (clobazam) Oral Film
Nov 01, 2018
LuMind Research Down Syndrome Foundation Launches the Down Syndrome Clinical Trials Network
Oct 23, 2018
Upsher-Smith Launches Generic Version Of Onfi® (clobazam), CIV In Tablet And Oral Suspension Dosage Forms
Oct 23, 2018
Breckenridge Announces Final Approval of its ANDA for Clobazam Tablets (Generic for Onfi®)
Jul 16, 2018
Upsher-Smith Launches Vigabatrin For Oral Solution Under The Brand Name Vigadrone(TM)
May 02, 2018
TRINTELLIX® (vortioxetine) Prescribing Information Now Includes New Data Showing Improvement in Processing Speed, an Important Aspect of Cognitive Function in Acute Major Depressive Disorder (MDD)
Mar 29, 2018
Behavioral Disorders Drug Development Pipeline Review 2017 - Key Players Involved in Therapeutic Development for Autism, OCD and ADHD
Nov 06, 2017
Takeda, Lundbeck and Advocate Health Care Research Study Aims to Enhance Patient-Provider Engagement in Major Depressive Disorder Treatment using Digital Technology
Aug 28, 2017
Endo Begins Shipment of Generic Sabril® (vigabatrin) for Oral Solution